|
USP6NL expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.12500000110694E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.72920000000621E-05 |
| Normal-vs-Stage2 |
8.16810000000556E-05 |
| Normal-vs-Stage3 |
9.36299999754198E-08 |
| Normal-vs-Stage4 |
1.30700000000594E-06 |
| Stage1-vs-Stage2 |
2.095200E-01 |
| Stage1-vs-Stage3 |
1.895830E-02 |
| Stage1-vs-Stage4 |
3.158200E-02 |
| Stage2-vs-Stage3 |
5.675200E-01 |
| Stage2-vs-Stage4 |
6.272600E-01 |
| Stage3-vs-Stage4 |
9.423800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.48959999960397E-07 |
| Normal-vs-AfricanAmerican |
9.207700E-04 |
| Normal-vs-Asian |
4.446400E-01 |
| Caucasian-vs-AfricanAmerican |
8.792200E-01 |
| Caucasian-vs-Asian |
3.022000E-01 |
| AfricanAmerican-vs-Asian |
3.758000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.81820000166866E-08 |
| Normal-vs-Female |
1.167280E-04 |
| Male-vs-Female |
8.132200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.255800E-03 |
| Normal-vs-Age(41-60Yrs) |
2.77420000005524E-06 |
| Normal-vs-Age(61-80Yrs) |
1.04609999995731E-07 |
| Normal-vs-Age(81-100Yrs) |
1.816070E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.604000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.262000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.351400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.661600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.230200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.427600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.995000E-01 |
| Normal-vs-Grade 2 |
5.362200E-04 |
| Normal-vs-Grade 3 |
2.70589994855186E-10 |
| Normal-vs-Grade 4 |
1.06700000002125E-06 |
| Grade 1-vs-Grade 2 |
3.267800E-01 |
| Grade 1-vs-Grade 3 |
1.159720E-02 |
| Grade 1-vs-Grade 4 |
4.464000E-02 |
| Grade 2-vs-Grade 3 |
4.989400E-04 |
| Grade 2-vs-Grade 4 |
1.422050E-02 |
| Grade 3-vs-Grade 4 |
8.560800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.154640E-04 |
| Normal-vs-ccB subtype |
9.19580000036113E-07 |
| ccA subtype-vs-ccB subtype |
6.911500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.68299999994781E-06 |
| Normal-vs-N1 |
2.621800E-01 |
| N0-vs-N1 |
6.073800E-01 |
|
|
